The challenge of diagnosing and classifying eosinophilia and eosinophil disorders: A review [0.03%]
嗜酸性粒细胞和嗜酸性粒细胞障碍的诊断与分类面临的挑战：综述
Agnieszka Szymczyk,Jakub Jaworski,Monika Podhorecka
Agnieszka Szymczyk
Eosinophilia is a feature of multiple conditions, both hematologic and non-hematologic, and may be associated with organ damage. The pathogenesis of eosinophilia can follow two distinct pathways. Primary eosinophilia is caused by a cell-int...
Aleksander Roszczyk,Michał Zych,Dariusz Sołdacki et al.
Aleksander Roszczyk et al.
The flow cytometry method could support physicians' decisions in the diagnosis and treatment monitoring of immunodeficient patients. Most clinical recommendations are focused on the search for alterations in T- and B-lymphocyte subsets, les...
Peripheral blood lymphocyte immunophenotyping (TBNK) - a comparison of BD FACSCanto II and BD FACSLyric flow cytometry analysers [0.03%]
外周血淋巴细胞免疫分型（TBNK）检测对比分析BD FACSCanto II和BD FACSLyric流式细胞仪的临床性能
Aleksandra Wiśniewska,Julia Stańczyk,Urszula Demkow et al.
Aleksandra Wiśniewska et al.
Introduction: Flow cytometry immunophenotyping is a common laboratory technique for evaluating lymphocyte subpopulations. Its result remains an important diagnostic tool in various medical fields. Cytometric tests are per...
An updated review of immunotherapy in esophageal cancer: PD-L1 footprint [0.03%]
食管癌免疫治疗现状及PD-L1检测更新
Juan Yao,Xiaoyan Tan,Yanping Sha et al.
Juan Yao et al.
Esophageal cancer is considered one of the most significant challenges to public health worldwide. While various therapeutic options exist for esophageal cancer, including chemotherapy, radiotherapy, and surgery, several adverse effects of ...
HLA class II DRB1, DQA1, DQB1 loci in patients with HIV infection and tuberculosis in a Latvian cohort group [0.03%]
拉脱维亚HIV感染和结核病患者队列中HLA-Ⅱ类DRB1、DQA1、DQB1位点分析
Alena Soha,Inga Azina,Baiba Rozentale et al.
Alena Soha et al.
Introduction: Until the COVID-19 pandemic, tuberculosis (TB) was the leading cause of death from a single infectious agent, ranking above HIV/AIDS. It is also the key cause of death among people infected with HIV. Tubercu...
High mobility group box protein 1 sensitizes mononuclear cells to further contact with lipopolysaccharide [0.03%]
高迁移率族箱蛋白1使单核细胞进一步接触脂多糖发生敏感化反应
Jakub Piotrowski,Tomasz Jędrzejewski
Jakub Piotrowski
Fever is an adaptive host-defense response to infection and nowadays is rightly considered to be an expression of a healthy body and a well-functioning immune system. The condition is that it must be tightly regulated. Therefore, in individ...
A study on the side effects caused by the Pfizer/BioNTech COVID-19 vaccine: Focus on IgG antibodies and serological biomarkers [0.03%]
针对辉瑞/BioNTech新冠疫苗副作用的一项研究：聚焦IgG抗体和血清生物标志物
Kameran M Ali,Ayad M Ali,Peshnyar M Atta et al.
Kameran M Ali et al.
Introduction: The SARS-CoV-2 pandemic that spread swiftly is now a major global public health issue. Vaccines are currently being distributed in an effort to limit the viral transmission and mortality. The aim of the stud...
Unveiling the interplay between influenza vaccination and SARS-CoV-2 immune responses [0.03%]
揭示流感疫苗与新型冠状病毒免疫反应之间的相互作用
Jacek Tabarkiewicz,Urszula Radzikowska,Andrzej Eljaszewicz
Jacek Tabarkiewicz
Influenza vaccination as a prognostic factor of humoral IgA responses to SARS-CoV-2 infection [0.03%]
流感疫苗接种作为预测IgA应对SARS-CoV-2感染的预后因素
Barbara Poniedziałek,Dominika Sikora,Ewelina Hallmann et al.
Barbara Poniedziałek et al.
There is evidence that influenza vaccination may provide additional benefits by inducing training of innate immunity and increasing humoral responses to heterologous challenges. Immunoglobulin A (IgA) antibodies dominate the early phase of ...
Immunological relationship between Helicobacter pylori and anti-tumor necrosis factor α agents in inflammatory bowel disease [0.03%]
Helicobacter pylori与炎症性肠病抗肿瘤坏死因子α药物的免疫关系
Han Huang,Chenxiao Gan,Yan Cai et al.
Han Huang et al.
Inflammatory bowel disease (IBD) is a group of diseases characterized by refractory and chronic inflammation of the bowel, which can be treated with biologics in clinical practice. Anti-tumor necrosis factor α (TNF-α) agents, which are am...